Richard M. Wright
CIK: 0001646423
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Celldex Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Nov 13, 2025CLDX
Celldex Therapeutics, Inc.
Exercise(M)Direct6.9K shares at avg. $9.02$62K - Nov 13, 2025CLDX
Celldex Therapeutics, Inc.
Exercise(M)Direct26.7K shares at avg. $10.38$277K - Nov 13, 2025CLDX
Celldex Therapeutics, Inc.
Exercise(M)Direct15.8K shares at avg. $22.48$354K - Nov 13, 2025CLDX
Celldex Therapeutics, Inc.
Sale(S)Direct49.3K shares at avg. $24.00$1.2M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | Exercise(M) | 6,876 | $9.02 | $61,997 | Direct |
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | Exercise(M) | 26,672 | $10.38 | $276,855 | Direct |
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | Exercise(M) | 15,750 | $22.48 | $354,060 | Direct |
| Nov 13, 2025 | CLDX Celldex Therapeutics, Inc. | Sale(S) | 49,298 | $24.00 | $1,183,177 | Direct |
1-4 of 4 transactions
About Wright Richard M.
Wright Richard M. (SEC CIK 0001646423) files insider reports with the SEC as Celldex Therapeutics, Inc. (CLDX).
Signal8 holds 1 ownership filing by Wright Richard M., a Form 4, filed on Nov 17, 2025. Those filings report 4 transactions, the latest on Nov 13, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Wright Richard M.'s filings is in HAMPTON, NJ.
Recent filings by Wright Richard M.
Other insiders filing for Celldex Therapeutics, Inc. (CLDX)
- Lawver Teri L, SVP & Chief Commercial Officer
- Jimenez Freddy A., SVP & GENERAL COUNSEL
- Young Diane C., SVP, CHIEF MEDICAL OFFICER
- Heath-Chiozzi Margo, SVP OF REGULATORY AFFAIRS
- Martin Samuel Bates, SVP AND CFO
- Cavanaugh Sarah, SVP OF CORP AFFAIRS & ADMIN.